top of page
eduo
visual
Infectious Diseases
Staphylococcal infections: MSSA, MRSA, scalded skin syndrome, toxic shock
Clinical Overview and When to Suspect Staphylococcal Infection
Staphylococcus aureus is one of the most versatile pediatric pathogens — causing disease ranging from superficial skin infections to life-threatening toxin-mediated syndromes.
— Direct invasion: skin/soft tissue infections (SSTI), osteoarticular infections, bacteremia, endocarditis, pneumonia, septic arthritis
— Toxin-mediated: staphylococcal scalded skin syndrome (SSSS), toxic shock syndrome (TSS), food poisoning
S. aureus is a Gram-positive coccus in clusters; coagulase-positive (distinguishes it from coagulase-negative staphylococci like S. epidermidis)
Two major clinical categories:
Suspect S. aureus when: purulent skin abscess, wound infection with golden-yellow pus, acute hematogenous osteomyelitis in a child, empyema complicating pneumonia, or a toxin-mediated presentation
Board pearl: Community-acquired MRSA (CA-MRSA) now accounts for the majority of pediatric SSTIs in many U.S. regions — always consider MRSA empirically for purulent skin infections
CA-MRSA strains typically carry PVL (Panton-Valentine leukocidin) gene → associated with necrotizing skin infections and necrotizing pneumonia
History — Key Elements for Staphylococcal Infections
Skin/soft tissue: ask about trauma, insect bites, skin breaks, contact sports, crowded living conditions, daycare exposure, household members with recurrent boils
Prior MRSA history: personal or household colonization dramatically ↑ risk of recurrence
Bone/joint: preceding trauma, refusal to bear weight, limp, fever + focal bony tenderness → think osteomyelitis or septic arthritis
TSS: ask about tampon use (menstrual TSS in adolescent females), recent surgical wound, nasal packing, burns, or skin wounds
SSSS: typically affects neonates and young children <5 years — ask about preceding impetigo, otitis media, or URI
Systemic illness: prolonged fever, weight loss, new cardiac murmur → consider endocarditis, especially with indwelling lines
Clinical tip: Recurrent MRSA SSTIs in a family cluster suggest household colonization → decolonization strategy should target all affected members
Physical Exam — Pattern Recognition by Syndrome
SSTI:
Osteoarticular infection:
SSSS:
TSS:
Abscess: fluctuant, tender, erythematous nodule ± spontaneous drainage of purulent material; often misdiagnosed as "spider bite"
Cellulitis: spreading erythema, warmth, induration; purulent (abscess-associated) vs non-purulent
Impetigo: honey-crusted lesions (non-bullous) or flaccid bullae (bullous — caused by exfoliative toxin)
Point tenderness over metaphysis (osteomyelitis) or joint effusion with limited ROM (septic arthritis)
Refusal to move extremity in infants (pseudoparalysis)
Diffuse, tender erythroderma → flaccid bullae → superficial desquamation with gentle lateral pressure (positive Nikolsky sign)
Perioral radial fissures, sparing of mucous membranes
High fever, diffuse macular erythroderma ("sunburn" rash), hypotension, multi-organ involvement, desquamation 1–2 weeks later (especially palms/soles)
Board pearl: SSSS spares mucous membranes; TSS involves mucous membranes (strawberry tongue, conjunctival injection)
Diagnostic Workup — Laboratory Evaluation
SSTI: Culture and sensitivity of purulent drainage is the most important test — guides targeted therapy; blood cultures rarely positive in uncomplicated SSTI
Bacteremia/invasive disease: Blood cultures (at least 2 sets before antibiotics), CBC with differential (leukocytosis, left shift, bandemia), CRP, ESR, procalcitonin
Osteomyelitis: ESR and CRP are elevated in >90%; blood cultures positive in ~50%; CRP useful for monitoring treatment response (normalizes faster than ESR)
TSS: Largely a clinical diagnosis; blood cultures often negative (toxin-mediated, not bacteremia); check CBC (↑ WBC), CMP (↑ Cr, ↑ LFTs, ↓ albumin), CK, coagulation studies, UA
SSSS: Clinical diagnosis; culture the suspected primary focus (nares, conjunctivae, periumbilical area in neonates), NOT the denuded skin (it is sterile — cleavage plane is in epidermis)
Board pearl: In SSSS the biopsy shows cleavage in the granular layer of the epidermis (superficial); in TEN (toxic epidermal necrolysis — the key differential) the split is at the dermal-epidermal junction (full-thickness) and involves mucous membranes
Diagnostic Workup — Imaging and Special Studies
Abscess: Bedside ultrasound is first-line to confirm fluid collection and guide drainage; sensitivity superior to exam alone
Osteomyelitis: MRI is the gold standard (sensitivity ~97%) — shows marrow edema early; plain radiographs are often normal in the first 10–14 days; bone scan is an alternative when MRI is unavailable
Septic arthritis: Ultrasound to identify joint effusion → arthrocentesis is both diagnostic and therapeutic; synovial fluid: WBC typically >50,000/μL with >75% PMNs, ↑ protein, ↓ glucose
Pneumonia with empyema: Chest radiograph shows dense consolidation ± pleural effusion; ultrasound characterizes effusion (simple vs loculated); CT with contrast if necrotizing pneumonia suspected
Endocarditis: Echocardiography (TTE first; TEE if TTE inadequate) for vegetations
Clinical tip: For suspected osteomyelitis with negative initial cultures, image-guided bone biopsy/aspiration improves pathogen identification and guides therapy — especially important in the MRSA era
Management — Skin and Soft Tissue Infections
— Antibiotics may be added for: abscess >5 cm, surrounding cellulitis, systemic symptoms, immunocompromised host, very young age, or failure to improve after I&D
— TMP-SMX (first-line for purulent SSTI; does NOT cover Group A Strep well → add cephalexin if concern for concurrent streptococcal cellulitis)
— Clindamycin (covers both MRSA and GAS; check D-test for inducible resistance)
— Doxycycline (age ≥8 years; good MRSA coverage)
Uncomplicated abscess (<5 cm, no systemic signs): Incision and drainage (I&D) alone is often sufficient; send wound culture
Empiric oral antibiotics when indicated (targeting CA-MRSA):
Non-purulent cellulitis (no abscess): likely β-hemolytic streptococcal → cephalexin or dicloxacillin first-line; add MRSA coverage only if not improving or risk factors present
Board pearl: TMP-SMX has poor activity against Group A Strep → for mixed purulent cellulitis, pair TMP-SMX with a β-lactam or use clindamycin alone
Management — Invasive MSSA and MRSA Infections
MSSA invasive disease (bacteremia, osteomyelitis, endocarditis):
MRSA invasive disease:
Board pearl: Never use daptomycin for pneumonia — it is inactivated by pulmonary surfactant
Nafcillin or oxacillin IV is first-line; cefazolin IV is an excellent alternative (better tolerated)
β-lactams are SUPERIOR to vancomycin for MSSA → always narrow to anti-staphylococcal β-lactam once MSSA confirmed
Vancomycin IV is first-line for serious MRSA infections; target trough AUC/MIC-based dosing (current practice moving toward AUC-guided dosing rather than trough-only)
Clindamycin IV if isolate is susceptible and D-test negative → can be used for non-endovascular infections (osteomyelitis, pneumonia)
Linezolid: alternative for MRSA pneumonia, SSTI, osteomyelitis; excellent oral bioavailability allows IV-to-PO step-down; monitor CBC for thrombocytopenia with prolonged use
Daptomycin: for bacteremia/endocarditis; NOT effective for pneumonia (inactivated by surfactant)
Duration varies: bacteremia 2–4 weeks, osteomyelitis typically 4–6 weeks, endocarditis 6 weeks
Management — Toxin-Mediated Staphylococcal Disease
SSSS (Staphylococcal Scalded Skin Syndrome):
Toxic Shock Syndrome (TSS):
— Clindamycin is critical: it inhibits toxin production (protein synthesis inhibitor) even when organisms are not actively dividing
Admit for IV anti-staphylococcal antibiotics — nafcillin/oxacillin (MSSA coverage first-line) ± vancomycin if MRSA risk
The toxin (exfoliative toxins A & B) cleaves desmoglein-1 in the superficial epidermis → supportive wound care, emollients, pain control
Avoid corticosteroids (unlike autoimmune blistering diseases)
Prognosis excellent in children (mortality <5%); much worse in adults and neonates with extensive involvement
Aggressive IV fluid resuscitation + vasopressors for refractory hypotension
Remove source (tampon, nasal packing, debride wound)
Antibiotics: vancomycin (empiric MRSA coverage) + clindamycin
IVIG may be considered in refractory cases (neutralizes superantigen toxins)
Board pearl: Clindamycin is added specifically to SUPPRESS toxin production in TSS — this is why it is paired with a cell-wall-active agent
Age-Specific Considerations — Neonates and Young Infants
Neonates are uniquely susceptible to staphylococcal infections due to immature innate immunity and skin barrier
Neonatal SSSS: Can be devastating; periumbilical area is a common primary infection site; presents with diffuse erythema → superficial desquamation; risk of sepsis, fluid/electrolyte losses, secondary infections
Late-onset neonatal sepsis (>72 hours): S. aureus (including MRSA) is an important pathogen, especially with indwelling central lines → empiric vancomycin + aminoglycoside
Neonatal osteomyelitis/septic arthritis: May present subtly — decreased movement of a limb (pseudoparalysis), irritability with diaper changes; contiguous spread across the growth plate to involve the epiphysis and joint is more common in neonates (transphyseal vessels present until ~18 months)
Board pearl: In neonates, osteomyelitis frequently spreads to the adjacent joint because transphyseal blood vessels allow infection to cross the growth plate — always image the joint in neonatal osteomyelitis
Bullous impetigo in neonates is caused by S. aureus exfoliative toxin (same mechanism as SSSS but localized)
Age-Specific Considerations — School-Age Children and Adolescents
— Menstrual TSS: adolescent female using tampons (especially super-absorbent); peak onset during menses; TSST-1 toxin
— Non-menstrual TSS: can follow any wound, surgical procedure, or nasal packing
School-age children: CA-MRSA SSTIs are extremely common; outbreaks in sports teams (wrestling, football) and daycare settings; furunculosis is the classic presentation
Musculoskeletal staph infections peak in the 5–15 year age group: acute hematogenous osteomyelitis classically involves the metaphysis of long bones (distal femur, proximal tibia most common)
PVL-positive CA-MRSA strains can cause necrotizing pneumonia — suspect in a previously healthy child with influenza-like illness followed by rapid respiratory deterioration, hemoptysis, leukopenia, and multilobar infiltrates
Adolescents:
Board pearl: PVL-positive MRSA necrotizing pneumonia often follows influenza — a previously healthy teen with flu → rapid decline, hemoptysis, leukopenia → think necrotizing staph pneumonia → add vancomycin + clindamycin empirically
Complications — SSTI and Invasive Disease
— Decolonization protocol: mupirocin 2% ointment to nares BID × 5 days + chlorhexidine body washes × 5 days for patient AND close contacts; dilute bleach baths (½ cup bleach per full bathtub) 2–3×/week
— Environmental measures: separate towels, frequent laundering, personal hygiene education
— Persistent S. aureus bacteremia (>72 hr despite appropriate antibiotics) → suspect endocarditis, undrained abscess, or infected hardware
Recurrent MRSA SSTIs: Occur in up to 50% of patients; driven by persistent nasal/skin colonization and household transmission
Bacteremia complications: Metastatic foci — endocarditis, osteomyelitis, septic emboli, deep tissue abscess
Osteomyelitis complications: Subperiosteal abscess, chronic osteomyelitis, pathologic fracture, growth plate damage → limb length discrepancy
Septic arthritis: Joint destruction if drainage is delayed; hip joint is an orthopedic emergency
Board pearl: S. aureus bacteremia requires repeat blood cultures at 48–72 hours to document clearance — persistent positivity mandates echocardiography and a search for metastatic foci
Complications — Toxin-Mediated Emergencies
SSSS complications:
TSS complications:
Fluid and electrolyte derangement (similar to burns — transepidermal water loss)
Secondary bacterial infection of denuded skin
Sepsis (especially in neonates)
Temperature dysregulation
Key distinction from TEN: SSSS has a superficial cleavage plane (intraepidermal — granular layer) → heals without scarring in 10–14 days; TEN has full-thickness epidermal necrosis → mucous membrane involvement, higher mortality, scarring
Multi-organ failure: renal failure (↑ Cr), hepatic dysfunction (↑ transaminases), ARDS, DIC, myocardial depression
Desquamation of palms and soles 1–2 weeks after onset (classic board image)
Recurrence: ~30% if not adequately treated with anti-toxin antibiotic and source removal; menstrual TSS recurs if tampon use resumes before seroconversion to TSST-1
Board pearl: TSS diagnostic criteria include fever ≥38.9°C (102°F), diffuse macular rash, hypotension, desquamation, and involvement of ≥3 organ systems — blood cultures are frequently NEGATIVE because disease is toxin-mediated, not bacteremic
Key Differentials — Staphylococcal Skin Disease
— SSSS: young children, Nikolsky-positive, superficial desquamation, mucous membranes SPARED, culture primary site (not skin), biopsy → intraepidermal split
— TEN: older children/adults, drug-related (sulfonamides, anticonvulsants, NSAIDs), mucous membranes INVOLVED, full-thickness epidermal necrosis, higher mortality
— Purulent (abscess-associated): likely S. aureus (often MRSA) → I&D ± TMP-SMX or clindamycin
— Non-purulent: likely Group A Streptococcus → cephalexin or amoxicillin-clavulanate
SSSS vs TEN (toxic epidermal necrolysis):
Bullous impetigo vs SSSS: Same toxin (exfoliative), but bullous impetigo is localized; SSSS is generalized dissemination of toxin
Staphylococcal abscess vs "spider bite": Many patients present attributing a CA-MRSA abscess to a spider bite → always culture purulent material
Cellulitis — purulent vs non-purulent:
Board pearl: If a patient reports a recurrent "spider bite" → think CA-MRSA abscess until proven otherwise
Key Differentials — Invasive and Toxin-Mediated Disease
— Staph TSS: TSST-1 or enterotoxin; diffuse macular rash early; desquamation later; often NO positive blood culture; associated with tampon use or wound
— Strep TSS: Group A Strep (GAS) with M-protein/streptococcal pyrogenic exotoxins; often bacteremic; necrotizing fasciitis common; NO classic diffuse rash; higher mortality
— S. aureus: older children (>4 years), high fever, markedly elevated CRP/ESR, toxic appearance
— K. kingae: younger children (6 months–4 years), may be indolent, preceded by URI/stomatitis, can be culture-negative on standard media (enhanced by PCR or inoculation into blood culture bottle)
Staph TSS vs Strep TSS:
Kawasaki disease vs TSS: Both cause fever, rash, conjunctival injection, strawberry tongue, desquamation → TSS has hypotension and multi-organ failure; Kawasaki has coronary artery involvement and is typically age <5 years
Septic arthritis: S. aureus vs Kingella kingae:
Board pearl: Kawasaki and TSS share many features — hypotension and multi-organ failure favor TSS; coronary aneurysms and age <5 favor Kawasaki
Prevention — MRSA Decolonization and Infection Control
— Intranasal mupirocin 2% BID × 5 days to all household members
— Chlorhexidine 4% body washes (or dilute bleach baths — ¼ to ½ cup regular bleach per full bathtub × 15 min, 2–3 times per week for 3 months)
— Personal hygiene: no sharing towels, razors, or personal items; frequent handwashing; laundering linens/towels in hot water
— Wound coverage: keep all skin lesions covered until healed
Decolonization for recurrent MRSA SSTIs:
Sports-related prevention: Shower immediately after contact sports; clean shared equipment; exclude athletes with draining wounds from contact until healed and covered
Healthcare-associated MRSA: Contact precautions (gown + gloves), hand hygiene, CHG bathing of ICU patients, screening/decolonization bundles for surgical patients
Board pearl: Decolonization should target ALL household members simultaneously to prevent recolonization from untreated contacts
Preventive Care — Vaccine-Related Considerations and Anticipatory Guidance
— Proper wound care for cuts, abrasions, and insect bites
— Hand hygiene education
— Avoid sharing personal items (towels, razors, sports equipment)
— Recognize early signs of skin infection: increasing redness, warmth, pain, drainage
There is currently NO licensed vaccine against S. aureus despite decades of research
Influenza vaccination is an important indirect preventive strategy: post-influenza secondary bacterial pneumonia (often S. aureus, including MRSA) carries high morbidity → annual influenza vaccine reduces this risk
Anticipatory guidance for families:
Tampon safety counseling for adolescent females: use lowest absorbency needed, change every 4–8 hours, alternate with pads, remove promptly; seek immediate care for fever + rash during menses
Board pearl: Post-influenza staphylococcal pneumonia is a classic board setup — previously healthy child recovering from influenza develops sudden fever, hemoptysis, and rapidly progressive pneumonia → think S. aureus (PVL+ MRSA) → cover empirically with vancomycin + clindamycin
Family Counseling and Psychosocial Considerations
Recurrent MRSA SSTIs cause significant family distress: repeated ER visits, I&D procedures, school absences, and fear of spreading infection
Reassure families that MRSA colonization does NOT mean they are "dirty" — CA-MRSA is widespread in the community
Explain the rationale for household decolonization: the entire family participates to break the cycle of recolonization
Discuss that recurrence is common (~50%) even with decolonization; adherence to hygiene measures ↓ but does not eliminate risk
Address stigma: some schools/daycares inappropriately exclude children — educate families that covered, non-draining lesions do not require exclusion
For TSS survivors: counsel about recurrence risk (~30% for menstrual TSS); avoid tampon use until TSST-1 antibody seroconversion confirmed; lifelong awareness of symptoms
For SSSS: reassure that prognosis is excellent in children — skin heals without scarring within 10–14 days with appropriate treatment
Clinical tip: Provide written decolonization instructions with specific product names, dilution ratios for bleach baths, and a clear timeline to improve family adherence
High-Yield Associations and Rapid-Fire Facts
S. aureus = coagulase-positive, catalase-positive, Gram-positive cocci in clusters
CA-MRSA = resistant to all β-lactams via mecA gene encoding PBP2a (altered penicillin-binding protein); often susceptible to TMP-SMX, clindamycin, doxycycline
SSSS toxin = exfoliative toxin A/B → cleaves desmoglein-1 → intraepidermal split at granular layer → Nikolsky-positive, mucous membranes SPARED
TSS toxin = TSST-1 (superantigen) → non-specific T-cell activation → massive cytokine release → shock + multi-organ failure
PVL toxin → leukocyte destruction → necrotizing skin infections and necrotizing pneumonia
Food poisoning: preformed enterotoxin → vomiting within 1–6 hours of ingestion → self-limited; NO fever (distinguishes from infectious diarrhea)
D-test: identifies inducible clindamycin resistance (erm gene); if D-zone positive → do NOT use clindamycin
Board pearl: S. aureus is the #1 cause of acute hematogenous osteomyelitis in children >4 years and the #1 cause of septic arthritis across all pediatric ages
Methicillin resistance = oxacillin resistance = resistance to ALL β-lactams (except ceftaroline, a fifth-generation cephalosporin)
One-Line Recap
S. aureus (MSSA and MRSA) causes a spectrum from purulent SSTIs (I&D is cornerstone; culture to guide therapy; TMP-SMX or clindamycin for CA-MRSA) to invasive disease (osteomyelitis — MRI is gold standard; nafcillin for MSSA, vancomycin for MRSA; always narrow antibiotics when sensitivities return) to toxin-mediated syndromes — SSSS (exfoliative toxin → superficial epidermal cleavage, Nikolsky-positive, mucous membranes SPARED, heals well in children) and TSS (TSST-1 superantigen → fever, diffuse erythroderma, hypotension, multi-organ failure, blood cultures often NEGATIVE → treat with source removal + clindamycin to suppress toxin + vancomycin for empiric MRSA coverage) — with CA-MRSA dominating community pediatric infections, making wound culture, D-test interpretation, household decolonization strategies, and recognition of PVL-associated necrotizing pneumonia post-influenza essential knowledge for the boards.
Board Question Stem Patterns
8-year-old with fever, refusal to bear weight, metaphyseal tenderness of tibia, ESR 65, CRP 8 → acute hematogenous osteomyelitis → MRI → blood cultures → empiric vancomycin (until MRSA ruled out) ± nafcillin
3-year-old with diffuse erythroderma, perioral fissuring, Nikolsky sign, intact mucous membranes → SSSS → IV nafcillin/oxacillin; NOT TEN (no mucosal involvement)
15-year-old female with fever, diffuse erythematous rash, hypotension during menses, using super-absorbent tampons → TSS → remove tampon, fluids, vancomycin + clindamycin
6-month-old with fluctuant, erythematous, tender 3-cm abscess → I&D + wound culture → if <5 cm and no systemic signs, antibiotics may not be needed; if cellulitis surrounding → add TMP-SMX or clindamycin
Previously healthy 12-year-old recovering from influenza → sudden high fever, hemoptysis, leukopenia, bilateral infiltrates → necrotizing MRSA pneumonia → vancomycin + clindamycin
Child with recurrent boils, mother and sibling also affected → CA-MRSA household cluster → wound culture + household decolonization (mupirocin + CHG/bleach baths for ALL)
Neonate with periumbilical erythema → diffuse skin peeling → SSSS → culture umbilicus, start IV anti-staph antibiotics
Lab reports clindamycin-susceptible, erythromycin-resistant S. aureus → next step: request D-test → if positive → do NOT use clindamycin (inducible resistance)
bottom of page